Literature DB >> 7558127

Expression of functional insulin-like growth factor-1 receptor on lymphoid cell subsets of rats.

X Xu1, C Mardell, C J Xian, H Zola, L C Read.   

Abstract

It has become evident that insulin-like growth factor-1 (IGF-1) acts as a growth factor for immune cells, yet the precise regulatory role of IGF-1 in the immune system is unknown. The aim of this study was to examine the distribution of IGF-1 receptors on rat lymphoid cells. A flow cytometric method was used, with a biotinylated and functionally active IGF-1 analogue, namely des(1-3)IGF-1, which binds well to IGF-1 receptor but poorly to IGF binding proteins, followed by phycoerythrin-conjugated streptavidin (PE-SA) staining. Our results showed that IGF-1 receptors were readily detectable on a wide variety of the immune cells, including T cells, B cells and monocytes, but the binding capacity for IGF-1 was monocytes > B cells > T cells, as determined by titration experiments. Furthermore, the level of expression on resting CD4+ T lymphocytes was greater than on CD8+ cells, and the concentration of biotin-des(1-3)IGF-1 required to demonstrate the binding to IGF-1 receptor on CD8+ cells (68 nmol/l) was 200-fold higher than for CD4+ cells (0.34 nmol/l), indicating that most of the IGF-1 receptor on CD8+ cells represented lower affinity sites. The level of IGF-1 receptor expression was increased several-fold after concanavalin A stimulation on both CD4+ and CD8+ T-cell subsets. Kinetic analysis of the expression of IGF-1 receptor and its association with interleukin-2 receptors (IL-2R) following activation showed a similar pattern, with no significant differences in the ratio of IGF-1 receptor: IL-2R per cell during the 3 days of cell culture. Our studies suggest that biological activities of IGF-1 include direct stimulation of immune cells, and that expression of IGF-1 receptor may have a role in regulation of T-cell function.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7558127      PMCID: PMC1383912     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  19 in total

Review 1.  Insulin-like growth factors and their binding proteins.

Authors:  E M Rutanen; F Pekonen
Journal:  Acta Endocrinol (Copenh)       Date:  1990-07

2.  The expression of insulin-like growth factors and their binding proteins in normal human lymphocytes.

Authors:  T Nyman; F Pekonen
Journal:  Acta Endocrinol (Copenh)       Date:  1993-02

Review 3.  The IL-2/IL-2 receptor system: a current overview.

Authors:  T Taniguchi; Y Minami
Journal:  Cell       Date:  1993-04-09       Impact factor: 41.582

4.  The interleukin-2 T-cell system: a new cell growth model.

Authors:  D A Cantrell; K A Smith
Journal:  Science       Date:  1984-06-22       Impact factor: 47.728

5.  The insulin-like growth factor 1 receptor is required for the proliferation of hemopoietic cells.

Authors:  K Reiss; P Porcu; C Sell; Z Pietrzkowski; R Baserga
Journal:  Oncogene       Date:  1992-11       Impact factor: 9.867

6.  Insulin receptor sub-types in a human lymphoid-derived cell line (IM-9): differential regulation by insulin, dexamethasone and monensin.

Authors:  H A Jonas; A J Cox
Journal:  J Recept Res       Date:  1991

7.  Effect of a major histocompatibility complex class I peptide on insulin-like growth factor-I receptor internalization and biological signaling.

Authors:  D Hsu; J M Olefsky
Journal:  Endocrinology       Date:  1993-09       Impact factor: 4.736

8.  Comparative binding of bovine, human and rat insulin-like growth factors to membrane receptors and to antibodies against human insulin-like growth factor-1.

Authors:  L C Read; F J Ballard; G L Francis; R C Baxter; C J Bagley; J C Wallace
Journal:  Biochem J       Date:  1986-01-01       Impact factor: 3.857

9.  Insulin-like growth factor-1 stimulation of lymphopoiesis.

Authors:  R Clark; J Strasser; S McCabe; K Robbins; P Jardieu
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

10.  Insulin-like growth factor-I binds selectively to human peripheral blood monocytes and B-lymphocytes.

Authors:  C A Stuart; R T Meehan; L S Neale; N M Cintron; R W Furlanetto
Journal:  J Clin Endocrinol Metab       Date:  1991-05       Impact factor: 5.958

View more
  3 in total

Review 1.  Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors:  Terry J Smith; Joseph A M J L Janssen
Journal:  Endocr Rev       Date:  2019-02-01       Impact factor: 19.871

Review 2.  Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?

Authors:  Terry J Smith
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

3.  Targeting the IGF-Axis Potentiates Immunotherapy for Pancreatic Ductal Adenocarcinoma Liver Metastases by Altering the Immunosuppressive Microenvironment.

Authors:  Masakazu Hashimoto; John David Konda; Stephanie Perrino; Maria Celia Fernandez; Andrew M Lowy; Pnina Brodt
Journal:  Mol Cancer Ther       Date:  2021-09-22       Impact factor: 6.009

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.